New entries in neuropsychiatry in 2016 Review article
Article Sidebar
Main Article Content
Abstract
The torrent of discoveries in neuroscience is being gradually translated into pharmaceutical and instrumental methods of CNS treatment. Innovative treatments such as the implantation of electrodes deep in the brain to treat severe neuropsychiatric disorders, and trials of new medications show promising results. They are based on a true understanding of how the brain functions in health and disease. It is more and more possible to guide treatment of neuropsychiatric disorders, coming up directly with basic principles grounded in neuroscience. The article outlines new drugs and technologies that make neuropsychiatric therapies more effective. Some new data about lifestyle that influence mental health are also presented.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: © Medical Education sp. z o.o. License allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
2. Nillni YI, Wesselink AK, Gradus JL et al. Depression, anxiety, and psychotropic medication use and fecundability. Am J Obstet Gynecol 2016; 215(4): 453.e1-453.e8.
3. Bandelow B, Sher L, Bunevicius R el al; WFSBP Task Force on Mental Disorders in Primary Care; WFSBP Task Force on Anxiety Disorders, OCD and PTSD. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract 2012; 16(2): 77-84.
4. Owen RT. Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety. Drugs Today 2007; 43(9): 601-610.
5. Sevigny J, Chiao P, Bussière T et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature 2016; 537(7618): 50-56.
6. Lozano AM, Fosdick L, Chakravarty MM et al. A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer’s Disease. J Alzheimers Dis 2016; 54(2): 777-787.
7. Wiler J. Mehrheit will konkretere Hilfe vom Arzt. Exit 2016; 3: 6-9.
8. Policja .
9. Bartyzel M, Łoza B, Grabowska A et al. Nowe formy cywilizacyjnej depresji i ich farmakologiczne leczenie. Neuropsychiatria 2016; 9(2): 67-71.
10. OECD .
11. IMS .
12. Kajitani S, McKenzie C, Sakata K. Use it too much and lose it? The effect of working hours on cognitive ability. Melbourne Institute Working Paper Series 2016; 7. The University of Melbourne, Melbourne 2016.
13. Wu L, Lu Y, Jiao Y et al. Paternal Psychological Stress Reprograms Hepatic Gluconeogenesis in Offspring. Cell Metab 2016; 23(4): 735-743.